TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8489
Avg. Estimate-0.19-0.18-0.73-0.56
Low Estimate-0.24-0.19-0.79-0.65
High Estimate-0.17-0.14-0.69-0.46
Year Ago EPS-0.17-0.16-0.59-0.73
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts9389
Avg. Estimate12.85M17.03M44.84M102.57M
Low Estimate10.7M13.88M30.4M82M
High Estimate13.8M20.5M47.5M125.96M
Year Ago Sales5.09M3.95M16.1M44.84M
Sales Growth (year/est)152.50%331.50%178.50%128.70%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.17-0.17-0.17-0.19
EPS Actual-0.17-0.16-0.23-0.13
Difference00.01-0.060.06
Surprise %0.00%5.90%-35.30%31.60%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.19-0.18-0.73-0.56
7 Days Ago-0.19-0.17-0.73-0.54
30 Days Ago-0.19-0.17-0.73-0.54
60 Days Ago-0.18-0.14-0.74-0.45
90 Days Ago-0.18-0.15-0.74-0.44
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-11.80%N/AN/A0.01
Next Qtr.-12.50%N/AN/A0.06
Current Year-23.70%N/AN/A-0.03
Next Year23.30%N/AN/A0.14
Next 5 Years (per annum)19.50%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A